Marc Ansari
- University of Geneva, Faculty of Medicine, Department of Pediatrics, Professor Associate
- Geneva University Hospital, Children and Adolescents Department, Division of Pediatric Onco-Hematology, Head of Unit
- University of Geneva, Faculty of Medicine, Department of Pediatrics, Pediatric Hematology and Oncology Research Platform, CANSEARCH Research Laboratory, Director
Since 2014, he has been a member of the European Pediatric Group of Blood and Marrow Transplantation and chair of the clinical trial committee as well as board member of the European Society of Pharmacogenomics and Individualized Therapy, chair of the scientific division. In 2016, he created and became Head of the Swiss Group of Pharmacogenomics and Individualized Therapy.
Prof. Marc Ansari has practiced in the medical field for over 19 years, particularly in the areas of pediatric oncology-hematology and pharmacogenetics, in Geneva and in Montreal. In 2011 he created the first pediatric hematology and oncology research platform of the Faculty of Medicine in Geneva and founded the same year the CANSEARCH Foundation in order to support its activities. Since January 2013, he is Head of the Pediatric Onco-Hematology Unit of the Geneva University Hospital (HUG). In November 2015, he was appointed Professor Assistant at the Faculty of Medicine of Geneva, and, in October 2018, Professor Associate.
Member: Swiss Association of Medical Assistants and Heads of Clinics, Swiss Society of Pediatrics, American Society of Hematology, International Society of Pediatric Oncology, Swiss Society of Pediatric Oncology, French Society of Childhood Tumors, French Society of Transplantation, Swiss Medical Association, Swiss Hemophilia Network, Swiss Blood Stem Cells, Children’s Cancer and Leukemia Group, German Pediatric Oncology Group.
Board Member: Pediatric Disease Working Group of European Blood and Marrow, European Society of Pharmacogenomics and Individualized Therapy, Swiss Society of Toxicology and Clinical Pharmacology, Swiss Group of Pharmacogenomics and Individualized Therapy (Founder and Director), DNA germline SPOG Working group (chairman), Children’s Hepatic tumors International Collaboration (CHIC-SIOPEL).
